atezolizumab
roche
['dante']
only 43% of patients completed post-op flot chemotherapy in preoperative dante trial. what chance do our real world patients have? #asco22
Medical Director, GI Oncology Program - AdventHealth Cancer Institute. Passionate about clinical research, education and pt-prov communication. #gicancer #meded